Goldman Sachs Group Inc Innoviva, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,161,874 shares of INVA stock, worth $22.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,161,874
Previous 910,443 27.62%
Holding current value
$22.2 Million
Previous $14.9 Million 50.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$16.33 - $20.04 $4.11 Million - $5.04 Million
251,431 Added 27.62%
1,161,874 $22.4 Million
Q2 2024

Aug 13, 2024
BUY
$14.4 - $16.4 $608,155 - $692,621
42,233 Added 4.86%
910,443 $14.9 Million
Q1 2024

May 15, 2024
SELL
$14.56 - $16.78 $2.38 Million - $2.74 Million
-163,421 Reduced 15.84%
868,210 $13.2 Million
Q4 2023

Feb 13, 2024
BUY
$12.32 - $16.27 $169,781 - $224,216
13,781 Added 1.35%
1,031,631 $16.5 Million
Q3 2023

May 14, 2024
SELL
$12.37 - $13.89 $170,470 - $191,418
-13,781 Reduced 1.34%
1,017,850 $13.2 Million
Q3 2023

Nov 14, 2023
SELL
$12.37 - $13.89 $20,930 - $23,501
-1,692 Reduced 0.17%
1,017,850 $13.2 Million
Q2 2023

May 14, 2024
BUY
$11.39 - $13.72 $5.98 Million - $7.2 Million
524,846 Added 106.09%
1,019,542 $13 Million
Q2 2023

Aug 14, 2023
BUY
$11.39 - $13.72 $5.98 Million - $7.2 Million
524,846 Added 106.09%
1,019,542 $13 Million
Q1 2023

May 14, 2024
SELL
$10.73 - $13.6 $2.41 Million - $3.06 Million
-224,669 Reduced 31.23%
494,696 $5.57 Million
Q1 2023

May 11, 2023
SELL
$10.73 - $13.6 $2.41 Million - $3.06 Million
-224,669 Reduced 31.23%
494,696 $5.57 Million
Q4 2022

May 14, 2024
SELL
$11.8 - $13.78 $4.18 Million - $4.88 Million
-354,138 Reduced 32.99%
719,365 $9.53 Million
Q4 2022

Feb 13, 2023
SELL
$11.8 - $13.78 $4.18 Million - $4.88 Million
-354,138 Reduced 32.99%
719,365 $9.53 Million
Q3 2022

May 14, 2024
SELL
$11.61 - $15.22 $590,925 - $774,667
-50,898 Reduced 4.53%
1,073,503 $12.5 Million
Q3 2022

Nov 10, 2022
SELL
$11.61 - $15.22 $590,925 - $774,667
-50,898 Reduced 4.53%
1,073,503 $12.5 Million
Q2 2022

May 14, 2024
BUY
$14.32 - $19.88 $1.33 Million - $1.84 Million
92,770 Added 8.99%
1,124,401 $16.6 Million
Q2 2022

Aug 15, 2022
BUY
$14.32 - $19.88 $3.96 Million - $5.5 Million
276,513 Added 32.61%
1,124,401 $16.6 Million
Q1 2022

May 16, 2022
BUY
$15.39 - $20.25 $6.33 Million - $8.33 Million
411,588 Added 94.34%
847,888 $16.4 Million
Q4 2021

Feb 14, 2022
BUY
$15.91 - $18.72 $1.66 Million - $1.95 Million
104,138 Added 31.35%
436,300 $7.53 Million
Q3 2021

Nov 10, 2021
BUY
$13.06 - $17.24 $4.34 Million - $5.73 Million
332,162 New
332,162 $5.55 Million

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email